Clinical trial

Tarlatamab for SCLC Brain Metastases

NCT07402343

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-08-01

PhasePHASE2

Study timeline

Study start (estimated)2026-08-01Date precision: month

Registry last updated2026-07-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Small Cell Lung Cancerunresolved

Brain Metastases, Adultunresolved

Interventions

TarlatamabDRUG · verified · RxNorm: tarlatamab

Sponsors & collaborators

Maastricht University Medical Centerlead sponsor

The Netherlands Cancer Institutecollaborator

Erasmus Medical Centercollaborator

University Medical Center Groningencollaborator

Mapped research locations

AmsterdamNetherlands1 GroningenNetherlands1 RotterdamNetherlands1 MaastrichtNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07402343 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.